News

The hiPS-HEP, with homogeneity, a long life span of stable CYP activity and reproducibility, provides a range of in vitro applications such as drug discovery, toxicity testing and

Amitiza is a chloride channel activator indicated for the treatment of chronic idiopathic constipation (CIC) in adults and for IBS-C in women aged 18 years and old. In

The product is a generic version of Warner Chilcott Company’s Lo Loestrin Fe, indicated for use by women to prevent pregnancy. Warner Chilcott filed suit against Watson in

The octreotide formulations incorporate Aegis’ Intravail/ProTek excipients suitable for all routes of administration including oral, buccal, metered nasal spray, or injection. The Intravail/ProTek excipients allow for non-invasive delivery

The company has started distribution of the generic version of GlaxoSmithKline’s Requip XL. Actavis CEO Doug Boothe said, "The launch of Ropinirole Extended-Release Tablets showcases Actavis’ commitment in

The Met inhibitor ARQ 197 plus Erlotinib vs Erlotinib plus placebo in NSCLC (MARQUEE) trial began enrollment in January 2011 and is being conducted under a Special Protocol

Pertzye is indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) or other conditions. DCI marketed Pertzye formulation for over a decade under

The company has begun the shipment of the product, which is bioequivalent to Novartis’ Prevacid OTC 24 hour capsules (15mg) and is indicated for the treatment of frequent

The company requires a strategic partner, additional funding, and interferon alpha-2b raw material support so as to begin any such trial. Helix, a developer of biopharmaceutical drug candidates